Recurrent Depression
 
 

 

 
 
 
 
 
 
 
 

Recurrent Depression
Story Tools: E-MAIL | PRINT Text Size: S M L XL

Synthetic marijuana, legal in U.S., causing outcry

Last Updated 30 Jul 2010, 09:01 +04:00

Psychiatry and Mental Health News »  

An herb and chemical blend dubbed K2 that is sold legally in the U.S. as incense but produces a marijuana-like high when smoked is landing a rising number of people in emergency rooms, doctors said.

The surge in calls to poison control centers across the country has spurred 10 states to ban K2 and other similar brands of so-called synthetic marijuana products.

It has also prompted public doctors who have treated patients who used K2 to issue health warnings.

"My first reaction to a product like this is ‘buyer beware,’” said Anthony Scalzo, director of toxicology at Cardinal Glennon Children’s Medical Center in St. Louis.

“You don’t know exactly what is in the product, the relative doses in the product, and there is no quality assurance,” he explained.

K2, defined by the Missouri Poison Center as a mix of herbs and spices that are sprayed with a psychoactive chemical, is likened to marijuana because the chemical compound produces a similar interaction with receptors in the brain.

Despite label warnings against consumption, smoking K2 has become a popular way to get high and pass drug screens. The product is sold online and at convenience stores and other outlets for roughly $30 to $40 for a 3-gram bag.

Users ranging from teens to adults in their 60s have suffered from agitation, anxiety, hypertension, vomiting and in some cases severe paranoia and hallucinations.

“These people come into an ER, they are extremely agitated,” Scalzo said. “They feel like their heart will beat out of their chest.”

The substance has also been linked to a suicide in Iowa and may have played a role in at least one other near-suicide, Scalzo said.

Scalzo, who also serves as the medical director for the Missouri Poison Center, said cases stemming from the use of K2 were considered rare just a year ago, when centers nationwide fielded just 13 related calls.

But with 766 cases already reported to poison control centers in 46 states and the District of Columbia during the first half of 2010, Scalzo fears “it may represent the tip of an iceberg.”

The American Association of Poison Control Centers said Missouri, Indiana, Georgia, Utah and Texas have the highest use of K2.

Alabama, Louisiana, North Dakota, Tennessee and Kentucky were among the first 10 states that have already passed some form of a ban, according to data from the National Conference of State Legislatures. Other states such as Nebraska are considering bans.

“We just don’t know what the long-term effects are and we need to address it,” said Nebraska State Senator Beau McCoy, who intends to introduce a bill next term prohibiting both selling and possession of K2.

McCoy is trying to write an inclusive bill that broadly bans the ingredients of the chemical compounds sprayed on the dried herb mix, preventing an alteration in the chemical makeup of the spray that would allow the substance back on the market.

---
By Lauren Keiper

BOSTON (Reuters Life!)




Related

Physically abused children report higher levels of psychosomatic symptoms
Study to determine whether fish oil can help prevent psychiatric disorders
Immigration at Young Age Ups Risk of Psychosis
Schizophrenia Tied to Teen Brain Changes
No Medical Explanation for ‘Crawling Skin’ Disease
Rare Genetic Mutations Linked To Bipolar Disorder
Brain Imaging Aids in Understanding Delusions

Section

Psychiatry and Mental Health News

Other Sections

Mood Episodes
Major Depressive Episode - Course
Depressive Disorders
Dysthymic Disorder Associated Features and Disorders
Bipolar Disorders
Bipolar I Disorder Diagnostic Features
Other Mood Disorders
Substance-Induced Mood Disorder Recording Procedures
Story Tools: E-MAIL | PRINT Text Size: S M L XL

Anxiety Disorders »

Specific Phobia (formerly Simple Phobia)
more »

Depressive Disorders »

Dysthymic Disorder Associated Features and Disorders
more »

Mood Disorders »

Hypomanic Episode Associated Features and Disorders
more »

Dissociative Disorders »

Dissociative Fugue (formerly Psychogenic Fugue)
more »

Bipolar Disorders »

Bipolar I Disorder Diagnostic Features
more »

Somatoform Disorders »

Hypochondriasis Specifier & Associated Features and Disorders
more »

  • Recurrent Depression
  • Recurrent Depression Feed
  • News »
  • Mood Disorders
  • L  Bipolar Disorders
  • L  Depressive Disorders
  • L  Mood Episodes
  • L  Other Mood Disorders
  •  
  • Somatoform Disorders
  • L  Body Dysmorphic Disorder
  • L  Conversion Disorder
  • L  Hypochondriasis
  • L  Pain Disorder
  • L  Somatization Disorder
  •  
  • Factitious Disorders
  • Dissociative Disorders
  • Anxiety Disorders
  • Personalized Depression Therapy
  • Histrionic Personality Disorder
  • Dependent Personality Disorder
  • Services »
  • RSS Feeds
  • Sign-up for Membership
  • Breaking News Archives
  • E-mail Newsletters
  • Contact us

About Us · Advertise With Us · Help · Privacy · Terms of Use · Contact Us ·           Copyright © 2005-2010

This project has been implemented by Armenian Medical Network with support of Living with Dementia Network